Use of strains of parapoxvirus ovis against organ fibrosis
AssigneeBayer Aktiengesellschaft
InventorsClaudia Hirth-Dietrich, Tobias Schlapp, Angela Siegling, Andreas Knorr, Olaf Weber, Gudrun Theiss
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use, in humans, of inactivated parapoxviruses for the prophylaxis and treatment of diseases which are accompanied by an increased deposition of collagen, with it being possible for both internal organs, such as the liver, and the skin and its appended structures, to be affected. The invention relates, in particular, to liver fibrosis and/or liver cirrhosis consequent upon virus hepatitis, or to ethanol-induced liver diseases and to cystic fibrosis.
Claims12
A method of treating organ fibroses in humans, comprising administering to a human an effective amount of an isolate of an inactivated parapoxvirus.
Dependencies are inferred from the claim text.